This study examined the prognostic effects of the adapted systemic inflammation score (aSIS), calculated from serum albumin and the lymphocyte‐to‐monocyte ratio, in a large cohort of 509 esophageal squamous cell carcinoma (ESCC) patients. Here, ALB is linked to esophageal squamous cell carcinoma.